ArticleJournal of animal science2026
Investigating the role of the bacterial metabolite ectoine on immune regulation within the bovine female reproductive tract.
Article in Journal of animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Ectoine, a compatible solute produced by extremophilic bacteria, is widely used for mucosal protection due to its cytoprotective and anti‑inflammatory properties. However, its effects within the female reproductive tract and its interaction with sperm‑associated immune responses remain unknown. This study provides the first assessment of ectoine's immunomodulatory activity in bovine cervical and uterine tissues and its influence on sperm-polymorphonuclear neutrophil (PMN) interactions. Cervical and uterine explants from follicular‑phase heifers (n = 5) were pre‑incubated with 0, 0.5, 5, or 50 mM ectoine prior to stimulation with lipopolysaccharide (LPS) or sperm. Cytokine concentrations (IL‑8, IL‑6, and IL‑1β) were measured by ELISA, and sperm-PMN binding and sperm motility following PMN co‑incubation were evaluated. Baseline cytokine secretion was higher in uterine versus cervical explants (P < 0.05), indicating distinct tissue‑specific immune profiles. Ectoine alone did not alter basal cytokine secretion (P > 0.05). LPS increased IL‑8, IL‑6, and IL‑1β secretion from cervical explants and IL‑8 and IL‑1β in uterine explants (P < 0.05), and ectoine did not modify these responses (P > 0.05). Sperm elevated IL‑1β release from uterine explants (P < 0.01), while IL‑6 and IL‑8 remained unchanged; this response was also unaffected by ectoine (P > 0.05). Ectoine did not influence sperm-PMN binding or sperm motility in the presence of PMNs (P > 0.05). Collectively, this study provides the first reproductive‑tract safety evaluation of ectoine, demonstrating that it does not disrupt constitutive or stimulus‑induced inflammatory signaling nor interfere with sperm-immune interactions. These findings support ectoine's safe incorporation into semen preservation and assisted reproductive technologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.